{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:57:15Z","timestamp":1791176235092,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"LG Life Science"},{"name":"Chunma medical research foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.tice.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,6]],"date-time":"2014-12-06T17:21:59Z","timestamp":1417886519000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Human adipose-derived stem cells attenuate inflammatory bowel disease in IL-10 knockout mice"],"prefix":"10.1016","volume":"47","author":[{"given":"Woo Yeun","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hwan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Gon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Snn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ik","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Hwan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2014.12.001_bib0005","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2165\/00003495-200565160-00002","article-title":"Biologic therapy for inflammatory bowel disease","volume":"65","author":"Ardizzone","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.tice.2014.12.001_bib0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/scd.2012.0273","article-title":"Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro","volume":"22","author":"Burlacu","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.tice.2014.12.001_bib0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1874467210801030195","article-title":"Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key","volume":"1","author":"Dharmani","year":"2008","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.tice.2014.12.001_bib0020","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study","volume":"59","author":"Duijvestein","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.tice.2014.12.001_bib0025","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.2174\/092986710791331095","article-title":"Mesenchymal stem cells in cartilage repair: state of the art and methods to monitor cell growth, differentiation and cartilage regeneration","volume":"17","author":"Galle","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tice.2014.12.001_bib0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cell.2010.01.023","article-title":"Homeostasis and inflammation in the intestine","volume":"140","author":"Garrett","year":"2010","journal-title":"Cell"},{"issue":"Suppl. 14","key":"10.1016\/j.tice.2014.12.001_bib0035","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1097\/00054725-200810001-00064","article-title":"Do different animal models of IBD serve different purposes?","volume":"2","author":"Grisham","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.tice.2014.12.001_bib0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.gastro.2012.10.043","article-title":"IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells","volume":"144","author":"Hasnain","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tice.2014.12.001_bib0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cgh.2011.11.026","article-title":"Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis","volume":"10","author":"Hyams","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tice.2014.12.001_bib0050","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.exphem.2004.02.004","article-title":"Mesenchymal stem cells: paradoxes of passaging","volume":"32","author":"Javazon","year":"2004","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.tice.2014.12.001_bib0055","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/MEG.0b013e32833eaa8a","article-title":"Infliximab for Crohn's disease in the Swiss IBD cohort study: clinical management and appropriateness","volume":"22","author":"Juillerat","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tice.2014.12.001_bib0060","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/nm.2542","article-title":"Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha","volume":"17","author":"Liu","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.tice.2014.12.001_bib0065","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1053\/j.gastro.2011.02.047","article-title":"Regulation of homeostasis and inflammation in the intestine","volume":"140","author":"MacDonald","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tice.2014.12.001_bib0070","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tice.2014.12.001_bib0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.mog.0000231808.10773.8e","article-title":"New mediators of immunity and inflammation in inflammatory bowel disease","volume":"22","author":"Monteleone","year":"2006","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.tice.2014.12.001_bib0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.trsl.2006.11.009","article-title":"Immune dysfunction in inflammatory bowel disease","volume":"149","author":"Neuman","year":"2007","journal-title":"Transl. Res.: J. Lab. Clin. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.tice.2014.12.001_bib0085","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1159\/000341131","article-title":"Animal models of inflammatory bowel diseases: illuminating the pathogenesis of colitis, ileitis and cancer","volume":"30","author":"Neurath","year":"2012","journal-title":"Dig. Dis."},{"key":"10.1016\/j.tice.2014.12.001_bib0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.20452\/pamw.614","article-title":"Biological therapy of inflammatory bowel disease","volume":"119","author":"Owczarek","year":"2009","journal-title":"Pol. Arch. Med. Wewn."},{"issue":"14 Suppl.","key":"10.1016\/j.tice.2014.12.001_bib0095","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/00054725-200810001-00065","article-title":"How have animal models of IBD contributed to advance IBD therapy?","volume":"2","author":"Rachmilewitz","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.tice.2014.12.001_bib0100","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI118878","article-title":"Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27\/human beta2 microglobulin transgenic rats","volume":"98","author":"Rath","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.tice.2014.12.001_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000068151","article-title":"Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease","volume":"70","author":"Schmidt","year":"2002","journal-title":"Pathobiology"},{"key":"10.1016\/j.tice.2014.12.001_bib0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","article-title":"Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25highFOXP3+ regulatory T cells","volume":"26","author":"Selmani","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.tice.2014.12.001_bib0115","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2741\/s115","article-title":"Stem cells as potential therapeutic targets for inflammatory bowel disease","volume":"2","author":"Singh","year":"2010","journal-title":"Frontiers Biosci."},{"key":"10.1016\/j.tice.2014.12.001_bib0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/jir.2007.0059","article-title":"CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-\/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition","volume":"28","author":"Singh","year":"2008","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.tice.2014.12.001_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12701\/yujm.2009.26.1.1","article-title":"Adult mesenchymal stem cells for cell therapy in clinical application","volume":"26","author":"Song","year":"2009","journal-title":"Yeungnam Univ. J. Med."},{"key":"10.1016\/j.tice.2014.12.001_bib0130","first-page":"149","article-title":"Experimental models of inflammatory bowel disease","volume":"51","author":"Stadnicki","year":"2003","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.tice.2014.12.001_bib0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.beha.2011.01.004","article-title":"Neuroprotective features of mesenchymal stem cells","volume":"24","author":"Uccelli","year":"2011","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.tice.2014.12.001_bib0140","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.tice.2014.12.001_bib0145","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI28568","article-title":"The stem cell niches in bone","volume":"116","author":"Yin","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.tice.2014.12.001_bib0150","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jcp.24150","article-title":"Generation, characterization and potential therapeutic applications of mature and functional hepatocytes from stem cells","volume":"228","author":"Zhang","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tice.2014.12.001_bib0155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/scd.2009.0345","article-title":"Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders","volume":"19","author":"Zhao","year":"2010","journal-title":"Stem Cells Dev."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816614001311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816614001311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:12:53Z","timestamp":1758571973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816614001311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0040816614001311"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2014.12.001","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human adipose-derived stem cells attenuate inflammatory bowel disease in IL-10 knockout mice","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}